Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-09-24 to 2025-09-25
Current total value of award: $5560.94
Description: 4569576025!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML